The global market for Montelukast Sodium Granules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Montelukast Sodium Granules is a drug used for the prevention and long-term treatment of asthma and relief of allergic rhinitis symptoms. Its main ingredient is montelukast sodium, which is a leukotriene receptor antagonist. Leukotrienes are chemicals that play a role in allergic reactions and inflammation. Montelukast helps control asthma symptoms by blocking leukotriene receptors, reducing inflammation and airway constriction.

North American market for Montelukast Sodium Granules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Montelukast Sodium Granules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Montelukast Sodium Granules include Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Montelukast Sodium Granules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast Sodium Granules.

The Montelukast Sodium Granules market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Montelukast Sodium Granules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Montelukast Sodium Granules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Montelukast Sodium Granules Market Report

Report Metric	Details
Report Name	Montelukast Sodium Granules Market
Segment by Type	5mg 10mg
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Montelukast Sodium Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Montelukast Sodium Granules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Montelukast Sodium Granules Market report?

Ans: The main players in the Montelukast Sodium Granules Market are Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals

What are the Application segmentation covered in the Montelukast Sodium Granules Market report?

Ans: The Applications covered in the Montelukast Sodium Granules Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Montelukast Sodium Granules Market report?

Ans: The Types covered in the Montelukast Sodium Granules Market report are 5mg, 10mg

1 Montelukast Sodium Granules Market Overview

1.1 Product Definition

1.2 Montelukast Sodium Granules by Type

1.2.1 Global Montelukast Sodium Granules Market Value Comparison by Type (2024 VS 2031)

1.2.2 5mg

1.2.3 10mg

1.3 Montelukast Sodium Granules by Application

1.3.1 Global Montelukast Sodium Granules Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Montelukast Sodium Granules Market Size Estimates and Forecasts

1.4.1 Global Montelukast Sodium Granules Revenue 2020-2031

1.4.2 Global Montelukast Sodium Granules Sales 2020-2031

1.4.3 Global Montelukast Sodium Granules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Montelukast Sodium Granules Market Competition by Manufacturers

2.1 Global Montelukast Sodium Granules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Montelukast Sodium Granules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Montelukast Sodium Granules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Montelukast Sodium Granules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Montelukast Sodium Granules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Montelukast Sodium Granules, Product Type & Application

2.7 Global Key Manufacturers of Montelukast Sodium Granules, Date of Enter into This Industry

2.8 Global Montelukast Sodium Granules Market Competitive Situation and Trends

2.8.1 Global Montelukast Sodium Granules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Montelukast Sodium Granules Players Market Share by Revenue

2.8.3 Global Montelukast Sodium Granules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Montelukast Sodium Granules Market Scenario by Region

3.1 Global Montelukast Sodium Granules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Montelukast Sodium Granules Sales by Region: 2020-2031

3.2.1 Global Montelukast Sodium Granules Sales by Region: 2020-2025

3.2.2 Global Montelukast Sodium Granules Sales by Region: 2026-2031

3.3 Global Montelukast Sodium Granules Revenue by Region: 2020-2031

3.3.1 Global Montelukast Sodium Granules Revenue by Region: 2020-2025

3.3.2 Global Montelukast Sodium Granules Revenue by Region: 2026-2031

3.4 North America Montelukast Sodium Granules Market Facts & Figures by Country

3.4.1 North America Montelukast Sodium Granules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Montelukast Sodium Granules Sales by Country (2020-2031)

3.4.3 North America Montelukast Sodium Granules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Montelukast Sodium Granules Market Facts & Figures by Country

3.5.1 Europe Montelukast Sodium Granules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Montelukast Sodium Granules Sales by Country (2020-2031)

3.5.3 Europe Montelukast Sodium Granules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Montelukast Sodium Granules Market Facts & Figures by Region

3.6.1 Asia Pacific Montelukast Sodium Granules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Montelukast Sodium Granules Sales by Region (2020-2031)

3.6.3 Asia Pacific Montelukast Sodium Granules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Montelukast Sodium Granules Market Facts & Figures by Country

3.7.1 Latin America Montelukast Sodium Granules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Montelukast Sodium Granules Sales by Country (2020-2031)

3.7.3 Latin America Montelukast Sodium Granules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Montelukast Sodium Granules Market Facts & Figures by Country

3.8.1 Middle East and Africa Montelukast Sodium Granules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Montelukast Sodium Granules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Montelukast Sodium Granules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Montelukast Sodium Granules Sales by Type (2020-2031)

4.1.1 Global Montelukast Sodium Granules Sales by Type (2020-2025)

4.1.2 Global Montelukast Sodium Granules Sales by Type (2026-2031)

4.1.3 Global Montelukast Sodium Granules Sales Market Share by Type (2020-2031)

4.2 Global Montelukast Sodium Granules Revenue by Type (2020-2031)

4.2.1 Global Montelukast Sodium Granules Revenue by Type (2020-2025)

4.2.2 Global Montelukast Sodium Granules Revenue by Type (2026-2031)

4.2.3 Global Montelukast Sodium Granules Revenue Market Share by Type (2020-2031)

4.3 Global Montelukast Sodium Granules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Montelukast Sodium Granules Sales by Application (2020-2031)

5.1.1 Global Montelukast Sodium Granules Sales by Application (2020-2025)

5.1.2 Global Montelukast Sodium Granules Sales by Application (2026-2031)

5.1.3 Global Montelukast Sodium Granules Sales Market Share by Application (2020-2031)

5.2 Global Montelukast Sodium Granules Revenue by Application (2020-2031)

5.2.1 Global Montelukast Sodium Granules Revenue by Application (2020-2025)

5.2.2 Global Montelukast Sodium Granules Revenue by Application (2026-2031)

5.2.3 Global Montelukast Sodium Granules Revenue Market Share by Application (2020-2031)

5.3 Global Montelukast Sodium Granules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Organon LLC

6.1.1 Organon LLC Company Information

6.1.2 Organon LLC Description and Business Overview

6.1.3 Organon LLC Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Organon LLC Montelukast Sodium Granules Product Portfolio

6.1.5 Organon LLC Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis Montelukast Sodium Granules Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Dong-A ST

6.3.1 Dong-A ST Company Information

6.3.2 Dong-A ST Description and Business Overview

6.3.3 Dong-A ST Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Dong-A ST Montelukast Sodium Granules Product Portfolio

6.3.5 Dong-A ST Recent Developments/Updates

6.4 Dr. Reddy's Laboratories

6.4.1 Dr. Reddy's Laboratories Company Information

6.4.2 Dr. Reddy's Laboratories Description and Business Overview

6.4.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio

6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pfizer Montelukast Sodium Granules Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Luye Pharma Group

6.6.1 Luye Pharma Group Company Information

6.6.2 Luye Pharma Group Description and Business Overview

6.6.3 Luye Pharma Group Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Luye Pharma Group Montelukast Sodium Granules Product Portfolio

6.6.5 Luye Pharma Group Recent Developments/Updates

6.7 Hengrui Medicine

6.7.1 Hengrui Medicine Company Information

6.7.2 Hengrui Medicine Description and Business Overview

6.7.3 Hengrui Medicine Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Hengrui Medicine Montelukast Sodium Granules Product Portfolio

6.7.5 Hengrui Medicine Recent Developments/Updates

6.8 Hybio Pharmaceutical

6.8.1 Hybio Pharmaceutical Company Information

6.8.2 Hybio Pharmaceutical Description and Business Overview

6.8.3 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio

6.8.5 Hybio Pharmaceutical Recent Developments/Updates

6.9 Teva Pharmaceutical Industries

6.9.1 Teva Pharmaceutical Industries Company Information

6.9.2 Teva Pharmaceutical Industries Description and Business Overview

6.9.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio

6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.10 Mylan Pharmaceuticals

6.10.1 Mylan Pharmaceuticals Company Information

6.10.2 Mylan Pharmaceuticals Description and Business Overview

6.10.3 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio

6.10.5 Mylan Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Montelukast Sodium Granules Industry Chain Analysis

7.2 Montelukast Sodium Granules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Montelukast Sodium Granules Production Mode & Process Analysis

7.4 Montelukast Sodium Granules Sales and Marketing

7.4.1 Montelukast Sodium Granules Sales Channels

7.4.2 Montelukast Sodium Granules Distributors

7.5 Montelukast Sodium Granules Customer Analysis

8 Montelukast Sodium Granules Market Dynamics

8.1 Montelukast Sodium Granules Industry Trends

8.2 Montelukast Sodium Granules Market Drivers

8.3 Montelukast Sodium Granules Market Challenges

8.4 Montelukast Sodium Granules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Organon

Novartis

Dong-A ST

Dr. Reddy’s Laboratories

Teva Pharmaceutical Industries

Mylan Pharmaceuticals

List of Tables

Table 1. Global Montelukast Sodium Granules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Montelukast Sodium Granules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Montelukast Sodium Granules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Montelukast Sodium Granules Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Montelukast Sodium Granules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Montelukast Sodium Granules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Montelukast Sodium Granules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Montelukast Sodium Granules Average Price (US$/kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Montelukast Sodium Granules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Montelukast Sodium Granules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Montelukast Sodium Granules, Product Type & Application

Table 12. Global Key Manufacturers of Montelukast Sodium Granules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Montelukast Sodium Granules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium Granules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Montelukast Sodium Granules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Montelukast Sodium Granules Sales by Region (2020-2025) & (kg)

Table 18. Global Montelukast Sodium Granules Sales Market Share by Region (2020-2025)

Table 19. Global Montelukast Sodium Granules Sales by Region (2026-2031) & (kg)

Table 20. Global Montelukast Sodium Granules Sales Market Share by Region (2026-2031)

Table 21. Global Montelukast Sodium Granules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Montelukast Sodium Granules Revenue Market Share by Region (2020-2025)

Table 23. Global Montelukast Sodium Granules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Montelukast Sodium Granules Revenue Market Share by Region (2026-2031)

Table 25. North America Montelukast Sodium Granules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Montelukast Sodium Granules Sales by Country (2020-2025) & (kg)

Table 27. North America Montelukast Sodium Granules Sales by Country (2026-2031) & (kg)

Table 28. North America Montelukast Sodium Granules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Montelukast Sodium Granules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Montelukast Sodium Granules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Montelukast Sodium Granules Sales by Country (2020-2025) & (kg)

Table 32. Europe Montelukast Sodium Granules Sales by Country (2026-2031) & (kg)

Table 33. Europe Montelukast Sodium Granules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Montelukast Sodium Granules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Montelukast Sodium Granules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Montelukast Sodium Granules Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Montelukast Sodium Granules Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Montelukast Sodium Granules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Montelukast Sodium Granules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Montelukast Sodium Granules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Montelukast Sodium Granules Sales by Country (2020-2025) & (kg)

Table 42. Latin America Montelukast Sodium Granules Sales by Country (2026-2031) & (kg)

Table 43. Latin America Montelukast Sodium Granules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Montelukast Sodium Granules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Montelukast Sodium Granules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Montelukast Sodium Granules Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Montelukast Sodium Granules Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Montelukast Sodium Granules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Montelukast Sodium Granules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Montelukast Sodium Granules Sales (kg) by Type (2020-2025)

Table 51. Global Montelukast Sodium Granules Sales (kg) by Type (2026-2031)

Table 52. Global Montelukast Sodium Granules Sales Market Share by Type (2020-2025)

Table 53. Global Montelukast Sodium Granules Sales Market Share by Type (2026-2031)

Table 54. Global Montelukast Sodium Granules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Montelukast Sodium Granules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Montelukast Sodium Granules Revenue Market Share by Type (2020-2025)

Table 57. Global Montelukast Sodium Granules Revenue Market Share by Type (2026-2031)

Table 58. Global Montelukast Sodium Granules Price (US$/kg) by Type (2020-2025)

Table 59. Global Montelukast Sodium Granules Price (US$/kg) by Type (2026-2031)

Table 60. Global Montelukast Sodium Granules Sales (kg) by Application (2020-2025)

Table 61. Global Montelukast Sodium Granules Sales (kg) by Application (2026-2031)

Table 62. Global Montelukast Sodium Granules Sales Market Share by Application (2020-2025)

Table 63. Global Montelukast Sodium Granules Sales Market Share by Application (2026-2031)

Table 64. Global Montelukast Sodium Granules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Montelukast Sodium Granules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Montelukast Sodium Granules Revenue Market Share by Application (2020-2025)

Table 67. Global Montelukast Sodium Granules Revenue Market Share by Application (2026-2031)

Table 68. Global Montelukast Sodium Granules Price (US$/kg) by Application (2020-2025)

Table 69. Global Montelukast Sodium Granules Price (US$/kg) by Application (2026-2031)

Table 70. Organon LLC Company Information

Table 71. Organon LLC Description and Business Overview

Table 72. Organon LLC Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 73. Organon LLC Montelukast Sodium Granules Product

Table 74. Organon LLC Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 78. Novartis Montelukast Sodium Granules Product

Table 79. Novartis Recent Developments/Updates

Table 80. Dong-A ST Company Information

Table 81. Dong-A ST Description and Business Overview

Table 82. Dong-A ST Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 83. Dong-A ST Montelukast Sodium Granules Product

Table 84. Dong-A ST Recent Developments/Updates

Table 85. Dr. Reddy's Laboratories Company Information

Table 86. Dr. Reddy's Laboratories Description and Business Overview

Table 87. Dr. Reddy's Laboratories Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 88. Dr. Reddy's Laboratories Montelukast Sodium Granules Product

Table 89. Dr. Reddy's Laboratories Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 93. Pfizer Montelukast Sodium Granules Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Luye Pharma Group Company Information

Table 96. Luye Pharma Group Description and Business Overview

Table 97. Luye Pharma Group Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 98. Luye Pharma Group Montelukast Sodium Granules Product

Table 99. Luye Pharma Group Recent Developments/Updates

Table 100. Hengrui Medicine Company Information

Table 101. Hengrui Medicine Description and Business Overview

Table 102. Hengrui Medicine Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 103. Hengrui Medicine Montelukast Sodium Granules Product

Table 104. Hengrui Medicine Recent Developments/Updates

Table 105. Hybio Pharmaceutical Company Information

Table 106. Hybio Pharmaceutical Description and Business Overview

Table 107. Hybio Pharmaceutical Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 108. Hybio Pharmaceutical Montelukast Sodium Granules Product

Table 109. Hybio Pharmaceutical Recent Developments/Updates

Table 110. Teva Pharmaceutical Industries Company Information

Table 111. Teva Pharmaceutical Industries Description and Business Overview

Table 112. Teva Pharmaceutical Industries Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 113. Teva Pharmaceutical Industries Montelukast Sodium Granules Product

Table 114. Teva Pharmaceutical Industries Recent Developments/Updates

Table 115. Mylan Pharmaceuticals Company Information

Table 116. Mylan Pharmaceuticals Description and Business Overview

Table 117. Mylan Pharmaceuticals Montelukast Sodium Granules Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 118. Mylan Pharmaceuticals Montelukast Sodium Granules Product

Table 119. Mylan Pharmaceuticals Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Montelukast Sodium Granules Distributors List

Table 123. Montelukast Sodium Granules Customers List

Table 124. Montelukast Sodium Granules Market Trends

Table 125. Montelukast Sodium Granules Market Drivers

Table 126. Montelukast Sodium Granules Market Challenges

Table 127. Montelukast Sodium Granules Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Montelukast Sodium Granules

Figure 2. Global Montelukast Sodium Granules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Montelukast Sodium Granules Market Share by Type: 2024 & 2031

Figure 4. 5mg Product Picture

Figure 5. 10mg Product Picture

Figure 6. Global Montelukast Sodium Granules Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Montelukast Sodium Granules Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Montelukast Sodium Granules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Montelukast Sodium Granules Market Size (2020-2031) & (US$ Million)

Figure 13. Global Montelukast Sodium Granules Sales (2020-2031) & (kg)

Figure 14. Global Montelukast Sodium Granules Average Price (US$/kg) & (2020-2031)

Figure 15. Montelukast Sodium Granules Report Years Considered

Figure 16. Montelukast Sodium Granules Sales Share by Manufacturers in 2024

Figure 17. Global Montelukast Sodium Granules Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Montelukast Sodium Granules Players: Market Share by Revenue in Montelukast Sodium Granules in 2024

Figure 19. Montelukast Sodium Granules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Montelukast Sodium Granules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Montelukast Sodium Granules Sales Market Share by Country (2020-2031)

Figure 22. North America Montelukast Sodium Granules Revenue Market Share by Country (2020-2031)

Figure 23. United States Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Montelukast Sodium Granules Sales Market Share by Country (2020-2031)

Figure 26. Europe Montelukast Sodium Granules Revenue Market Share by Country (2020-2031)

Figure 27. Germany Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Montelukast Sodium Granules Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Montelukast Sodium Granules Revenue Market Share by Region (2020-2031)

Figure 34. China Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Montelukast Sodium Granules Sales Market Share by Country (2020-2031)

Figure 42. Latin America Montelukast Sodium Granules Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Montelukast Sodium Granules Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Montelukast Sodium Granules Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Montelukast Sodium Granules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Montelukast Sodium Granules by Type (2020-2031)

Figure 53. Global Revenue Market Share of Montelukast Sodium Granules by Type (2020-2031)

Figure 54. Global Montelukast Sodium Granules Price (US$/kg) by Type (2020-2031)

Figure 55. Global Sales Market Share of Montelukast Sodium Granules by Application (2020-2031)

Figure 56. Global Revenue Market Share of Montelukast Sodium Granules by Application (2020-2031)

Figure 57. Global Montelukast Sodium Granules Price (US$/kg) by Application (2020-2031)

Figure 58. Montelukast Sodium Granules Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions